If you have just been diagnosed with bipolar disorder, or you are reviewing your medication for bipolar disporder options because what you are on now is not working, you have probably noticed how confusing the field can be. There are mood stabilizers, antipsychotics, antidepressants, and anticonvulsants used as mood stabilizers. There are FDA-approved options, off-label options, and combinations. There are also strong opinions everywhere about what works and what does not.
This guide walks through every major class of medication used to treat bipolar disorder, what each does, the trade-offs, and how a psychiatrist thinks about choosing between them. The aim is not to tell you what to take. That decision belongs to you and your prescriber, working from your specific diagnosis, episode history, and what your body tolerates. The aim is to make you a better-informed participant in that conversation.
How medication fits into bipolar disorder treatment
Medication is the cornerstone of bipolar disorder treatment, but it is rarely the whole picture. Bipolar disorder is a lifelong condition for most people who have it, and the goal of medication is twofold: end an active episode (mania, hypomania, or bipolar depression) and prevent the next one. Without treatment, the extreme mood swings between these states recur and often intensify over time. Maintenance treatment, which is the second goal, is where most of the long-term work happens.
Two realities matter early on. First, finding the right medication or combination usually takes time and adjustment. It is rare for someone to land on the perfect regimen on the first try, and that is not a failure of treatment, it is how the process works. Second, medication works best when paired with other supports: psychotherapy, sleep regularity, alcohol moderation, and a consistent daily structure. The Cleveland Clinic and the American Psychiatric Association both treat psychosocial interventions as part of the standard of care, not as an optional add-on.
If you are looking for ongoing care in this area, I provide bipolar medication management in NJ and bipolar medication management in NYC. What follows is the medication picture itself.
The four main classes of bipolar medication
Bipolar medication falls into four broad categories. Many treatment plans use medications from more than one category at the same time, particularly for bipolar I disorder.
Mood stabilizers include lithium and several anticonvulsant medications used at mood-stabilizing doses. They are the foundation of long-term maintenance treatment and the first-line option for classic euphoric mania.
Antipsychotics, specifically second-generation antipsychotics, are used for acute mania, mixed episodes, bipolar depression, and maintenance. Several are FDA-approved specifically for bipolar disorder.
Antidepressants are sometimes used for the depressive phase of bipolar disorder, but cautiously and almost always alongside a mood stabilizer. The reason is the manic switch risk, which I cover in detail below.
Adjunct medications include sleep aids, anti-anxiety medications, and other agents used to manage specific symptoms or side effects. These are not standalone treatments for bipolar disorder.
Mood stabilizers: lithium and the anticonvulsants
Lithium has been the gold standard for bipolar disorder treatment since the 1970s. Decades of evidence support it as the most effective long-term mood stabilizer, particularly for preventing manic relapse, and it is the only medication shown to reduce suicide risk in bipolar disorder. For classic euphoric mania, current guidelines from the American Psychiatric Association still place lithium as a first-line option.
Lithium has real trade-offs. It has a narrow therapeutic range, which means blood levels need monitoring. A level too low does not work; a level too high causes toxicity. Long-term use can affect kidney function and thyroid function, so regular blood work is required for anyone on lithium maintenance. Common side effects include tremor, increased thirst, increased urination, and weight gain. None of this disqualifies lithium, but it does mean lithium requires a prescriber willing to manage it carefully.
Three anticonvulsants are commonly used as mood stabilizers. Valproate (also called valproic acid or divalproex) is effective for acute mania and as maintenance treatment. It has been used widely for decades. It is generally avoided in people who can become pregnant because of significant risks to fetal development. Lamotrigine is approved for maintenance treatment of bipolar disorder, with strongest evidence for preventing depressive episodes. It needs slow titration when starting because of a risk of a serious rash (Stevens-Johnson syndrome) if introduced too quickly. Carbamazepine is effective for mania and is sometimes used when lithium and valproate have not worked. It interacts with many other medications, which complicates dosing for anyone on other drugs.
Each of these has a different niche. Lithium is the strongest preventer of manic relapse and the only medication with clear evidence for reducing suicide. Lamotrigine is the strongest preventer of depressive relapse but is not a strong anti-manic agent. Valproate is solid across both phases but has reproductive concerns. Your prescriber will weigh these against your specific history.
Antipsychotics for mania, mixed episodes, and bipolar depression
Second-generation antipsychotics have become central to bipolar treatment over the past two decades. They are effective for acute mania, mixed episodes, and (in several specific cases) bipolar depression. Several are also used for long-term maintenance.
The antipsychotics most commonly used in bipolar disorder include quetiapine, olanzapine, risperidone, aripiprazole, lurasidone, cariprazine, asenapine, and lumateperone. Each has different FDA-approved indications within bipolar disorder, and these matter for which phase your prescriber will reach for each medication.
For bipolar depression specifically (the depressive phase of bipolar disorder, which is what most patients spend the majority of their time in), several antipsychotics have FDA approval: quetiapine, lurasidone, cariprazine, lumateperone, and the olanzapine-fluoxetine combination (Symbyax). This is important because, as the next section explains, standard antidepressants alone are not the first choice for bipolar depression. The antipsychotics with bipolar depression approval are.
Side effects are the main downside of this class. Second-generation antipsychotics carry metabolic risks: weight gain, elevated cholesterol, elevated blood sugar, and (over time) increased risk of diabetes. Some are worse than others on this front. Olanzapine and quetiapine sit at the more difficult end of the metabolic spectrum; lurasidone, aripiprazole, and lumateperone tend to be more metabolically neutral. Sedation, restlessness (akathisia), and movement-related side effects also vary by medication. A prescriber who knows your priorities (energy, weight, sedation tolerance) can match the medication to what you can live with long-term.
The antidepressant question, and why your psychiatrist may be cautious
This is one of the most misunderstood areas of bipolar treatment, so it is worth slowing down.
Antidepressants, particularly SSRIs and SNRIs, are commonly prescribed for depression. If someone is depressed and has not been diagnosed with bipolar disorder, an antidepressant is often the first medication tried. The problem is that for someone who actually has bipolar disorder, an antidepressant on its own can trigger a switch into mania or hypomania. This is called the manic switch risk, and it is the central reason your prescriber will be cautious about antidepressants if you have bipolar disorder.
The risk is not theoretical. Studies have estimated that 10 to 25 percent of people with bipolar disorder treated with antidepressant monotherapy switch into mania or hypomania, with higher risk in bipolar I than bipolar II. Beyond the immediate switch risk, antidepressant monotherapy can also worsen the long-term course of bipolar illness by destabilizing mood cycling. For these reasons, current treatment guidelines do not recommend antidepressants as first-line monotherapy for bipolar depression in either bipolar I or bipolar II.
What is recommended instead, when an antidepressant is being considered in bipolar disorder, is layering one carefully on top of an existing mood stabilizer or antipsychotic. The mood stabilizer or antipsychotic acts as a brake on the manic switch risk. Even with that protection, antidepressants are typically used for shorter courses in bipolar disorder than in unipolar depression, and the switch is monitored for closely. For many patients, the better option is one of the antipsychotics that has FDA approval specifically for bipolar depression (quetiapine, lurasidone, cariprazine, lumateperone, or the olanzapine-fluoxetine combination), because these treat the depressive episode without the switch risk.
If your previous prescriber put you on an antidepressant alone and you experienced what felt like euphoric energy, racing thoughts, decreased sleep, or impulsive decisions, that is information worth sharing in your next evaluation. A retroactive recognition of antidepressant-induced hypomania can clarify a bipolar II diagnosis that was missed.
How psychiatrists choose the right medication (and adjust it)
The choice of bipolar medication is not a flowchart, but there is a logic to it. The questions a careful prescriber will work through include:
What is the diagnosis, specifically? Bipolar I (with full manic episodes) and bipolar II (with hypomanic episodes only) have overlapping but not identical first-line options. Cyclothymic disorder, which involves longer cycles of milder symptoms, is treated differently again. Your prescriber will want a careful history of every elevated and depressive episode you can remember, including ones you may not have thought of as episodes.
What phase are you in now? An active manic episode, an active depressive episode, or maintenance between episodes all call for different starting points. Acute mania often means lithium or an antipsychotic for rapid symptom control. Acute bipolar depression often means an antipsychotic with depression approval (quetiapine, lurasidone, lumateperone, cariprazine) or the olanzapine-fluoxetine combination. Maintenance after an episode is where lithium, lamotrigine, or a long-term antipsychotic comes into focus.
What is your episode history? Someone who has had three manic episodes and one depression looks different on paper from someone who has had two severe depressions and one brief hypomania. The pattern shapes which preventive medication makes the most sense.
What can your body tolerate? A patient who has gained 40 pounds on olanzapine in the past will need a different antipsychotic. A patient with kidney concerns will need careful thought about lithium. Pregnancy plans, planned or possible, change the calculus on valproate and several other medications.
What else is going on? Bipolar disorder commonly co-occurs with anxiety disorders, ADHD, and substance use. These affect medication choice and sequence. ADHD with bipolar disorder is its own careful conversation, which I cover in more depth on the ADHD and bipolar disorder page.
The timeline for finding the right regimen matters too. Mood stabilizers typically take several weeks to show their full effect. Antipsychotics work faster for acute mania (days) but their preventive benefit takes longer to evaluate. Most prescribers will not declare a medication a failure before six to eight weeks at an appropriate dose, assuming side effects are tolerable. The “trial and error” reality of bipolar medication is not a bug, it is how the response is actually assessed.
My approach combines clinical evaluation with a biological-systems framing. I trained in molecular and cellular biology before clinical practice, and I use that background to think carefully about which mechanisms are likely at play for a given patient and which medications are most likely to address them. The personalization is the point. There is no single best medication for bipolar disorder. There is a best medication for you, and finding it is the work.
Side effects, monitoring, and what to expect
Every medication in this guide has side effects. Some are short-term and resolve within a few weeks of starting; some are long-term and need to be managed across years of treatment. Knowing what to expect makes them less alarming when they appear.
Lithium requires blood level checks via a simple blood test (typically every few months once stable, more frequently when starting or adjusting dose), plus periodic kidney function tests and thyroid function tests. Common side effects include tremor, increased thirst, frequent urination, and weight gain. Toxicity at high blood levels is a real risk and is why monitoring matters.
Valproate requires periodic liver function tests and blood counts. Side effects can include weight gain, hair thinning, and gastrointestinal symptoms. The reproductive concerns mentioned earlier are significant.
Lamotrigine requires slow upward dose titration over several weeks to minimize the rash risk. Once at maintenance dose, ongoing monitoring is minimal, which is one reason lamotrigine is well tolerated for long-term use.
Carbamazepine interacts with many medications and lowers blood levels of some hormonal contraceptives, which matters if pregnancy prevention depends on hormonal birth control.
Antipsychotics require periodic metabolic monitoring: weight, fasting blood sugar, lipid panel. Movement-related side effects (tremor, restlessness, in rare cases tardive dyskinesia with long-term use) need to be watched for and addressed early if they appear.
If a side effect appears that bothers you, contact your prescriber. Many side effects can be managed by dose adjustment, timing changes (taking medication at night instead of morning, for example), or switching to a different option in the same class. Stopping a bipolar medication abruptly without medical guidance can precipitate a relapse, so any change should be discussed first. For more on what ongoing medication management looks like in practice, see Medication Management in NJ: What to Expect From a Psychiatrist.
For someone whose bipolar depression has not responded to standard options, there are next steps. I cover those on the treatment-resistant depression page, which is relevant when bipolar depression is the persistent issue.
When to take the next step
Bipolar disorder is one of the most treatable serious psychiatric conditions, and the medication options have expanded significantly over the past two decades. The hard part is usually finding a prescriber who will take the time to understand your specific history, work through medication choices methodically, and adjust the plan as your response unfolds.
I provide precision psychiatry and medication management to patients in New Jersey (in-person at Fort Lee) and New York (telehealth). Initial consultations are 50 minutes and cover your full picture: diagnosis, episode history, what has and has not worked, and what a tailored plan would look like.
For trusted general reference on bipolar disorder, the National Institute of Mental Health page is a solid starting point.
